160 related articles for article (PubMed ID: 28859143)
1. The effect of wool hydrolysates on squamous cell carcinoma cells in vitro. Possible implications for cancer treatment.
Damps T; Laskowska AK; Kowalkowski T; Prokopowicz M; Puszko AK; Sosnowski P; Czuwara J; Konop M; Różycki K; Borkowska JK; Misicka A; Rudnicka L
PLoS One; 2017; 12(8):e0184034. PubMed ID: 28859143
[TBL] [Abstract][Full Text] [Related]
2. Enhanced death ligand-induced apoptosis in cutaneous SCC cells by treatment with diclofenac/hyaluronic acid correlates with downregulation of c-FLIP.
Fecker LF; Stockfleth E; Braun FK; Rodust PM; Schwarz C; Köhler A; Leverkus M; Eberle J
J Invest Dermatol; 2010 Aug; 130(8):2098-109. PubMed ID: 20237495
[TBL] [Abstract][Full Text] [Related]
3. Ingenol mebutate: induced cell death patterns in normal and cancer epithelial cells.
Stahlhut M; Bertelsen M; Hoyer-Hansen M; Svendsen N; Eriksson AH; Lord JM; Scheel-Toellner D; Young SP; Zibert JR
J Drugs Dermatol; 2012 Oct; 11(10):1181-92. PubMed ID: 23134983
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the effectiveness of cisplatin and 5-fluorouracil on cutaneous squamous human carcinoma cell line: Potential chemotherapy alternative to surgery.
Gil S; Yébenes M; Luelmo J; Alsina M; Sabés M
Dermatol Ther; 2016 Sep; 29(5):341-344. PubMed ID: 27292650
[TBL] [Abstract][Full Text] [Related]
5. Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
Philipp-Dormston WG
Curr Probl Dermatol; 2015; 46():115-21. PubMed ID: 25561215
[TBL] [Abstract][Full Text] [Related]
6. Ingenol mebutate field-directed treatment of UVB-damaged skin reduces lesion formation and removes mutant p53 patches.
Cozzi SJ; Ogbourne SM; James C; Rebel HG; de Gruijl FR; Ferguson B; Gardner J; Lee TT; Larcher T; Suhrbier A
J Invest Dermatol; 2012 Apr; 132(4):1263-71. PubMed ID: 22189786
[TBL] [Abstract][Full Text] [Related]
7. Cationic membrane-active peptides - anticancer and antifungal activity as well as penetration into human skin.
Do N; Weindl G; Grohmann L; Salwiczek M; Koksch B; Korting HC; Schäfer-Korting M
Exp Dermatol; 2014 May; 23(5):326-31. PubMed ID: 24661024
[TBL] [Abstract][Full Text] [Related]
8. Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma.
Tampucci S; Carpi S; Digiacomo M; Polini B; Fogli S; Burgalassi S; Macchia M; Nieri P; Manera C; Monti D
Molecules; 2019 May; 24(9):. PubMed ID: 31075867
[TBL] [Abstract][Full Text] [Related]
9. Actinic keratosis is squamous cell carcinoma.
Lober BA; Lober CW
South Med J; 2000 Jul; 93(7):650-5. PubMed ID: 10923948
[TBL] [Abstract][Full Text] [Related]
10. Syntheses, biological evaluation and SAR of ingenol mebutate analogues for treatment of actinic keratosis and non-melanoma skin cancer.
Liang X; Grue-Sørensen G; Månsson K; Vedsø P; Soor A; Stahlhut M; Bertelsen M; Engell KM; Högberg T
Bioorg Med Chem Lett; 2013 Oct; 23(20):5624-9. PubMed ID: 23993332
[TBL] [Abstract][Full Text] [Related]
11. Imiquimod - Its role in the treatment of cutaneous malignancies.
Bubna AK
Indian J Pharmacol; 2015; 47(4):354-9. PubMed ID: 26288465
[TBL] [Abstract][Full Text] [Related]
12. Human polymerase alpha inhibitors for skin tumors. Part 2. Modeling, synthesis and influence on normal and transformed keratinocytes of new thymidine and purine derivatives.
Höltje M; Richartz A; Zdrazil B; Schwanke A; Dugovic B; Murruzzu C; Reissig HU; Korting HC; Kleuser B; Höltje HD; Schäfer-Korting M
J Enzyme Inhib Med Chem; 2010 Apr; 25(2):250-65. PubMed ID: 20222764
[TBL] [Abstract][Full Text] [Related]
13. Topical pharmacotherapy for skin cancer: part II. Clinical applications.
Micali G; Lacarrubba F; Nasca MR; Ferraro S; Schwartz RA
J Am Acad Dermatol; 2014 Jun; 70(6):979.e1-12; quiz 9912. PubMed ID: 24831325
[TBL] [Abstract][Full Text] [Related]
14. Ectopic coexpression of keratin 8 and 18 promotes invasion of transformed keratinocytes and is induced in patients with cutaneous squamous cell carcinoma.
Yamashiro Y; Takei K; Umikawa M; Asato T; Oshiro M; Uechi Y; Ishikawa T; Taira K; Uezato H; Kariya K
Biochem Biophys Res Commun; 2010 Aug; 399(3):365-72. PubMed ID: 20659422
[TBL] [Abstract][Full Text] [Related]
15. Topical application of valrubicin has a beneficial effect on developing skin tumors.
Andersen SM; Rosada C; Dagnaes-Hansen F; Laugesen IG; de Darkó E; Dam TN; Stenderup K
Carcinogenesis; 2010 Aug; 31(8):1483-90. PubMed ID: 20554745
[TBL] [Abstract][Full Text] [Related]
16. Ultradeformable liposomes as multidrug carrier of resveratrol and 5-fluorouracil for their topical delivery.
Cosco D; Paolino D; Maiuolo J; Marzio LD; Carafa M; Ventura CA; Fresta M
Int J Pharm; 2015 Jul; 489(1-2):1-10. PubMed ID: 25899287
[TBL] [Abstract][Full Text] [Related]
17. Topical and light-based treatments for actinic keratoses.
Silapunt S; Goldberg LH; Alam M
Semin Cutan Med Surg; 2003 Sep; 22(3):162-70. PubMed ID: 14649583
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin.
Hodges A; Smoller BR
Mod Pathol; 2002 Nov; 15(11):1121-5. PubMed ID: 12429789
[TBL] [Abstract][Full Text] [Related]
19. Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part I: Topical Treatments.
Gracia-Cazaña T; González S; Gilaberte Y
Actas Dermosifiliogr; 2016 Nov; 107(9):730-739. PubMed ID: 27436800
[TBL] [Abstract][Full Text] [Related]
20. Rapidly-growing squamous cell carcinoma shortly after treatment with ingenol mebutate for actinic keratoses: report of two cases.
Moreno Romero JA; Campoy A; Perez N; Garcia F; Grimalt R
Br J Dermatol; 2015 Dec; 173(6):1514-7. PubMed ID: 26227007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
